NEW YORK--(BUSINESS WIRE)--INNOVIVE Pharmaceuticals, Inc. (OTCBB:IVPH) today announced the appointment of Philip Frost, M.D., Ph.D., to the company’s Board of Directors, effective May 1, 2007. Dr. Frost brings to the company more than 30 years of experience in the fields of cell biology and oncology pharmaceutical research and development.
